XML 17 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Statements of Operations and Comprehensive Income (Loss) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenues:    
Total Revenues $ 137,735 $ 24,329
Operating expenses:    
Cost of goods sold 10,075 11,652
Research and development 13,403 31,381
Selling, general and administrative 41,988 29,901
Total operating expenses 65,466 72,934
Income (loss) from operations 72,269 (48,605)
Interest expense (14,024) (14,387)
Other income, net 2,777 1,273
Net income (loss) $ 61,022 $ (61,719)
Net income (loss) per common share - basic (in dollars per share) $ 0.36 $ (0.79)
Net income (loss) per common share - diluted (in dollars per share) $ 0.34 $ (0.79)
Weighted-average shares outstanding - basic (in shares) 169,258,564 78,440,266
Weighted-average shares outstanding - diluted (in shares) 189,641,251 78,440,266
Other comprehensive income (loss):    
Unrealized gain on investments $ 0 $ 1
Comprehensive income (loss) 61,022 (61,718)
Product sales, net    
Revenues:    
Total Revenues 24,756 17,031
Collaboration revenue    
Revenues:    
Total Revenues $ 112,979 $ 7,298